- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | J&J jumps on the MFN pricing train | ||
| Fr | FDA turns down Hetlioz for jet lag once again | ||
| Fr | Now Iktos teams up with Pierre Fabre in oncology | ||
| Fr | Parabilis scores $305m in bumper biofinancing week | ||
| Fr | Report says MSD is in talks to buy Revolution Meds | ||
| Do | Servier signs €1bn-plus AI pact with Iktos | ||
| Do | Court blocks HHS' 340B rebate programme pilot | ||
| Do | Study finds weight returns more quickly in GLP-1 users | ||
| Do | Hengrui gets first OK for a PD-L1/TGF-beta drug for cancer | ||
| Do | OpenAI launches ChatGPT Health portal | ||
| Mi | Hutchmed scores with drug for rare autoimmune disease | ||
| Mi | Is Lilly negotiating to buy Ventyx Bio? | ||
| Mi | Bayer's Monsanto sues mRNA COVID-19 vaccine makers | ||
| Mi | NICE endorses digital tools for people with asthma | ||
| Mi | GSK preps filings for chronic hepatitis B drug bepirovirsen | ||
| Di | Amgen inks $840m takeover of UK's Dark Blue Therapeutics | ||
| Di | Lilly taps Nimbus for another obesity candidate | ||
| Di | Alumis shoots up as its Sotyktu rival aces psoriasis trials | ||
| Di | More details emerge of NHS online hospital due next year | ||
| Di | RNA specialist Ribo files $205m IPO in Hong Kong | ||
| Di | CDC cuts recommended childhood jabs from 17 to 11 | ||
| 05.01. | Aktis Oncology files much-expanded IPO | ||
| 05.01. | Insilico adds Sanofi to partnership roster with $888m deal | ||
| 05.01. | China clears GSK's Nucala for COPD | ||
| 05.01. | Sanofi seeks use of type 1 diabetes drug in younger kids |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .